This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Infantile Malignant Osteopetrosis
Information about Infantile Malignant Osteopetrosis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Infantile Malignant Osteopetrosis
Most recent studies have shown that Infantile Malignant Osteopetrosis shares some biological mechanisms with albers-schonberg-disease, anemia, bone-diseases, exanthema, extramedullary-hematopoiesis-(disorder), fracture, graft-vs-host-disease, hemorrhage, hereditary-diseases, immunologic-deficiency-syndromes, infective-disorder, malignant-paraganglionic-neoplasm, osteomyelitis, osteoporosis, pancytopenia, retinal-degeneration, rickets, sclerosis.
Among the many pathways, these few ones have gauged particular interests from scientists studying Infantile Malignant Osteopetrosis, and have been seen in publications frequently: Aging, Bone Remodeling, Bone Resorption, Cell Differentiation, Chondrocyte Differentiation, Eye Development, Immune Response, Inflammatory Response, Localization, Lymph Node Development, Ossification, Osteoclast Development, Osteoclast Differentiation, Pathogenesis, Pigmentation, Proteolysis, Proton Transport, Secretion, Tooth Eruption, Transport
Quite a number of genes have been found to play important roles in Infantile Malignant Osteopetrosis, such as ACP5, ATP6AP1, BGLAP, CA2, CLCN7, FCER1G, IL7, MITF, NFATC1, OSTM1, TCIRG1, TDRD7, TNF, TNFRSF11A, TNFRSF11B, TNFSF11, TYROBP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.